These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9219539)

  • 1. Solution structure of neuropeptide tyrosine 13-36, a Y2 receptor agonist, as determined by NMR.
    Labelle M; St-Pierre S; Savard R; Boulanger Y
    Eur J Biochem; 1997 Jun; 246(3):780-5. PubMed ID: 9219539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilized structure of the presynaptic (Y2) receptor-specific neuropeptide Y analog N-acetyl[Leu-28,Leu-31]NPY(24-36).
    Barden JA; Cuthbertson RM; Potter EK; Selbie LA; Tseng A
    Biochim Biophys Acta; 1994 Jun; 1206(2):191-6. PubMed ID: 8003524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structure of the Y1 receptor agonist [Leu31, Pro34]NPY as determined by NMR and molecular modeling.
    Khiat A; Labelle M; Boulanger Y
    J Pept Res; 1998 Apr; 51(4):317-22. PubMed ID: 9560007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the presynaptic (Y2) receptor-specific neuropeptide Y analog ANA-NPY.
    Barden JA; Cuthbertson RM; Potter EK
    Biochim Biophys Acta; 1995 Jul; 1250(1):83-9. PubMed ID: 7612657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure by 2D 1H-NMR of a chimeric peptide recognized by galanin and neuropeptide Y receptors.
    Arvidsson K; Land T; Langel U; Bartfai T; Ehrenberg A
    Biochemistry; 1993 Aug; 32(30):7787-98. PubMed ID: 7688568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterizations of neuropeptide tyrosine (NPY) and its agonist analog [Ahx5-17]NPY by NMR and molecular modeling.
    Boulanger Y; Chen Y; Commodari F; Senécal L; Laberge AM; Fournier A; St-Pierre S
    Int J Pept Protein Res; 1995 Jan; 45(1):86-95. PubMed ID: 7775012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helical structure and self-association in a 13 residue neuropeptide Y Y2 receptor agonist: relationship to biological activity.
    Barnham KJ; Catalfamo F; Pallaghy PK; Howlett GJ; Norton RS
    Biochim Biophys Acta; 1999 Nov; 1435(1-2):127-37. PubMed ID: 10561544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor.
    Rist B; Zerbe O; Ingenhoven N; Scapozza L; Peers C; Vaughan PF; McDonald RL; Wieland HA; Beck-Sickinger AG
    FEBS Lett; 1996 Sep; 394(2):169-73. PubMed ID: 8843157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure by 1H and dynamics by natural abundance 13C NMR of a receptor recognising peptide derived from a C-terminal fragment of neuropeptide Y.
    Arvidsson K; Jarvet J; Allard P; Ehrenberg A
    J Biomol NMR; 1994 Sep; 4(5):653-72. PubMed ID: 7919952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
    Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
    Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY.
    Barden JA
    Biochem Biophys Res Commun; 1995 Oct; 215(1):264-71. PubMed ID: 7575600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of human calcitonin gene-related peptide (hCGRP) and of its antagonist hCGRP 8-37 as determined by NMR and molecular modeling.
    Boulanger Y; Khiat A; Chen Y; Senécal L; Tu Y; St-Pierre S; Fournier A
    Pept Res; 1995; 8(4):206-13. PubMed ID: 8527874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of the helical structure of Y2-selective analogues of neuropeptide Y by lactam bridges.
    Yao S; Smith-White MA; Potter EK; Norton RS
    J Med Chem; 2002 May; 45(11):2310-8. PubMed ID: 12014969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y.
    Uegaki K; Murase S; Nemoto N; Kobayashi Y; Yoshikawa S; Yumoto N
    Biochem Biophys Res Commun; 1997 Dec; 241(3):737-43. PubMed ID: 9434778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Galanin N-terminal fragment (1-15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype.
    Díaz-Cabiale Z; Parrado C; Narváez M; Millón C; Puigcerver A; Fuxe K; Narváez JA
    Regul Pept; 2010 Aug; 163(1-3):130-6. PubMed ID: 20451563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unwinding of the C-Terminal Residues of Neuropeptide Y is critical for Y₂ Receptor Binding and Activation.
    Kaiser A; Müller P; Zellmann T; Scheidt HA; Thomas L; Bosse M; Meier R; Meiler J; Huster D; Beck-Sickinger AG; Schmidt P
    Angew Chem Int Ed Engl; 2015 Jun; 54(25):7446-9. PubMed ID: 25924821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational analysis of neuropeptide Y segments by CD, NMR spectroscopy and restrained molecular dynamics.
    Gurrath M; Bisello A; Bottazzo K; Chung CW; Mammi S; Peggion E
    J Pept Sci; 1996; 2(3):176-93. PubMed ID: 9231326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.